Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer in vitro and in vivo

References

• Amiri, S., et al., 2020. Betulin and its derivatives as novel compounds with different pharmacological effects. Biotechnology advances, 38 (19), 107409–130100.
   PubMedGoogle Scholar
• Andreyev., H.J., et al., 1998. Comments on: why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies. European journal of cancer 1998, 34, 503–509.
   PubMed Web of Science ®Google Scholar
• Barea, M.J., et al., 2010. Evaluation of liposomes coated with a pH responsive polymer. International journal of pharmaceutics, 402 (1-2), 89–94.
   PubMed Web of Science ®Google Scholar
• Barea, M.J., et al., 2012. Encapsulation of liposomes within pH responsive microspheres for oral colonic drug delivery. International journal of biomaterials, 2012, 2012, 1–8.
   Google Scholar
• Beloqui, A., des Rieux, A., and Préat, V., 2014. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. International journal of pharmaceutics, 473 (1-2), 203–212.
   PubMed Web of Science ®Google Scholar
• Berenguer, F.M.A., et al., 2020. Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer. Journal of brachytherapy, 19 (1), 51–59.
   Web of Science ®Google Scholar
• Bertheloot, D. and Latz, E., 2017. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cellular & molecular immunology, 14 (1), 43–64.
   PubMed Web of Science ®Google Scholar
• Camarg, J.F., et al., 2009. CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation. Journal of immunology, 182 (1), 171–182.
   Web of Science ®Google Scholar
• Cotte, A.K., et al., 2018. Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance. Nature communications 322, 9 (1), 322.
   PubMedGoogle Scholar
• Franco, P.I., et al., 2020. Tumor microenvironment components: allies of cancer progression. Pathology, research and practice, 216 (1), 152729.
   PubMed Web of Science ®Google Scholar
• Gheorgheosu, D., et al., 2014. Betulinic acid as a potent and complex antitumor phytochemical: a minireview. Anti-cancer agents in medicinal chemistry, 14 (7), 936–945.
   PubMed Web of Science ®Google Scholar
• Huang, A., et al., 2011. N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin. Drug delivery, 8 18,562–569.
   PubMed Web of Science ®Google Scholar
• Huang, J.R., et al., 2019. Liposomal irinotecan for treatment of colorectal cancer in a preclinical model. Cancers, 11 (3), 281.
   Web of Science ®Google Scholar
• Jain, D., Panda, A.K., and Majumdar, D.K., 2005. Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech, 6 (1), E100–E107.
   PubMed Web of Science ®Google Scholar
• Kim, P.S., et al., 2016. IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas. Oncotarget, 7 (13), 16130–16145.
   PubMedGoogle Scholar
• Krajewska, J.B., Bartoszek, A., and Fichna, J., 2019. New trends in liposome-based drug delivery in colorectal cancer. Mini reviews in medicinal chemistry, 19 (1), 3–11.
   PubMed Web of Science ®Google Scholar
• Krijgsman, D., et al., 2019. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Cancer immunology immunotherapy, 68 (6), 1011–1024.
   PubMed Web of Science ®Google Scholar
• Lamprecht, A., Schäfer, U., and Lehr, C.M., 2001. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharmaceutical research, 18 (6), 788–793.
   PubMed Web of Science ®Google Scholar
• Lu, K. B., et al., 2020. Apoptosis activation in thyroid cancer cells by jatrorrhizine-platinum(II) complex via downregulation of PI3K/AKT/mammalian target of rapamycin (mTOR) pathway. Medical science monitor, 26, e922518.
   Google Scholar
• Luo, W., et al., 2010. Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin. Cancer immunology immunotherapy, 59 (2), 247–256.
   PubMed Web of Science ®Google Scholar
• Maierbrugger, K.T., Rita, S.N., and Bateman, J.M., 2020. The mTOR pathway component unkempt regulates neural stem cell and neural progenitor cell cycle in the Drosophila central nervous system. Developmental biology, 461 (1), 55–65.
   PubMed Web of Science ®Google Scholar
• Mullauer, F.B., Kessler, J.H., and Medema, J.P., 2010. Betulinic acid, a natural compound with potent anticancer effects. Anti-cancer drugs, 21 (3), 215–227.
   PubMed Web of Science ®Google Scholar
• Opattova, A., et al., 2019. Ganoderma lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo. Mutation research genetic toxicology and environmental mutagenesis, 845, 403065.
   PubMed Web of Science ®Google Scholar
• Rebecca, S., Deepa, N., and Ahmedin, J., 2013. Cancer statistics, 2013. CA: a cancer journal for clinicians, 63 (1), 11–30.
   PubMed Web of Science ®Google Scholar
• Ríos, J.L. and Máñez, S., 2018. New pharmacological opportunities for betulinic acid. Planta medica, 84 (1), 8–19.
   PubMed Web of Science ®Google Scholar
• Sakpakdeejaroen, I., et al., 2019. Transferrin-bearing liposomes entrapping plumbagin for targeted cancer therapy. Journal of interdisciplinary nanomedicine, 4 (2), 54–71.
   PubMedGoogle Scholar
• Saravanakumar, K., et al., 2019. Emerging strategies in stimuli-responsive nanocarriers as the drug delivery system for enhanced cancer therapy. Current pharmaceutical design, 25 (24), 2609–2625.
   PubMed Web of Science ®Google Scholar
• Scheper, W., et al., 2019. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nature medicine, 25 (1), 89–94.
   PubMed Web of Science ®Google Scholar
• Sconocchia, G., et al., 2014. NK cells and T cells cooperate during the clinical course of colorectal cancer. Oncoimmunology, 3 (8), e952197.
   PubMed Web of Science ®Google Scholar
• Slagter, M., et al., 2019. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nature Medicine, 25 (1), 89–94.
   PubMed Web of Science ®Google Scholar
• Song, L.L. and Li, Y.M., 2016. Current noninvasive tests for colorectal cancer screening: an overview of colorectal cancer screening tests. World journal of gastrointestinal oncology, 8 (11), 793–800.
   PubMed Web of Science ®Google Scholar
• Stifter, K., et al., 2020. A tumor-specific neoepitope expressed in homologous/self or heterologous/viral antigens induced comparable effector CD8+ T-cell responses by DNA vaccination. Vaccine, 38 (21), 3711–3719.
   PubMed Web of Science ®Google Scholar
• Takimoto, C.H., et al., 1996. Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin cancer research, 2 (3), 477–481.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2017. Overaccumulation of p53-mediated autophagy protects against betulinic acid-induced apoptotic cell death in colorectal cancer cells. Cell death & disease, 8 (10), e3087.
   PubMedGoogle Scholar
• West, N.R., et al., 2015. Emerging cytokine networks in colorectal cancer. Nature reviews immunology, 15 (10), 615–629.
   PubMed Web of Science ®Google Scholar
• Xing, L., et al., 2003 Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. J control release 2003, 93, 293–300.
   PubMed Web of Science ®Google Scholar
• Yao, Y., et al., 2017. MHC class II peptides induce CD8 + CD44 + Ly49+ regulatory T cells in C57BL/6 mice . Cell immunology, 312, 71–77.
   PubMed Web of Science ®Google Scholar
• Zhang, D.M., et al., 2015. Betulinic acid and its derivatives as potential antitumor agents. Medicinal research reviews, 35 (6), 1127–1155.
   PubMed Web of Science ®Google Scholar
• Zhou, X.M., et al., 2018. Intrinsic expression of immune checkpoint molecule TIGIT could help tumor growth in vivo by suppressing the function of NK and CD8+ T cells. Frontiers in immunology, 9, 2821
   PubMed Web of Science ®Google Scholar
• Zhu, P., et al., 2017. Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesis. Biomedicine & pharmacotherapy, 95, 68–76.
   PubMed Web of Science ®Google Scholar